OncoBayes

CompanyUnited Kingdom

OncoBayes develops one asset, preclinical (OB-001 in cancer). Mostly small molecule; based in the United Kingdom.

1
Asset
Furthest stage
Preclinical
0
Trials
0
Signals

Pipeline

1
  • OB-001

    Overcomes ADC resistance and penetrates the blood-brain barrier to target tumors

    Preclinical, Small molecule, cancer, oncology

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Similar companies6

Intelligence